Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:14-01-2011
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:Change of Registered Office of the Company
Bliss GVS Pharma Ltd has informed BSE that the Registered Office of the Company pursuant to the provisions of section 146 of the Companies Act, 1956, the Registered Office of the Company situated at 6/29-A, Udit Mittal Industry, Andheri Kurla Road, Andheri - East, Mumbai - 400 059 shifted to 102, Hyde Park, Sakivihar Road, Andheri - East, Mumbai - 400 072 with effect from December 25, 2010.Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:Purchase of Shares
Bliss GVS Pharma Ltd has informed BSE that Mr. Gautam R. Ashra has purchased 45000 equity Shares of the Company from the following name:1. Name : Mr. Gautam R. Ashra- No of Shares Buy : 7500- Average Rate : Rs. 37.40 per share2. Name : Kanji Forex Pvt. Ltd.- No of Shares Buy : 16500- Average Rate : Rs. 37.40 per share3. Name : Mrs. Prabhavati R. Ashra (Mother of Mr. Gautam R. Ashra)- No of Shares Buy : 21000- Average Rate : Rs. 37.40 per share.Fixes Record Date for Interim Dividend
Bliss GVS Pharma Ltd has informed BSE that November 27, 2010 has been fixed as the Record Date for the purpose of Payment of Interim Dividend.Financial Results for Sep 30, 2010
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the Quarter ended September 30, 2010.Board declare Interim Dividend
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on November 11, 2010, inter alia, approved;1. The Board declare 30% Interim Dividend; and2. The Company has decided to change its registered office from 6/29A, Udit Mittal Industry, Andheri Kurla Road, Andheri (East), Mumbai - 400059 to 102, Hyde Park, Saki Vihar Road, Andheri (East) Mumbai - 400 072 w.e.f.25th December 2010.Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Gautam R Ashra has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:Disclosures under Reg. 7(1A) of SEBI (SAST) Regulations, 1997
Gautam R Ashra has submitted the disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE: